CURX

Pharma

Alzheimer’s disease: Curaxis wants drug partner by 3Q 2012

Drug developer Curaxis Pharmaceutical (PINK:CURX) aims to find a drug partner this year who could help the cash-strapped company resume clinical trials on its experimental Alzheimer’s disease treatment. Curaxis Chairman and interim CEO Timothy Wright said in a letter to shareholders that the company is focused on attracting bridge financing between $1 million and $2 […]